Accelrys' Q3 Revenues Inch up 1 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Accelrys reported after the close of the market Wednesday that its third quarter revenues increased 1 percent year over year due primarily to a boost from its professional services.

The San Diego-based science informatics firm reported total revenues of $40.9 million for the three months ended Sept. 30, compared to $40.5 million for the third quarter of 2012. On a non-GAAP basis, which includes a deferred revenue fair value adjustment, its revenue for the quarter was $44.3 million, beating the average Wall Street estimate of $43.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.